Journal of Enzyme Inhibition and Medicinal Chemistry

SJR Rank #7,213H-index: 103SJR: 0.776Best quartile: Q2Open AccessAPC: US$2,306Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Drug DiscoveryQ2
  • Medicine (miscellaneous)Q2
  • PharmacologyQ2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Synthesis and biological activityEnzyme function and inhibitionCholinesterase and Neurodegenerative DiseasesSynthesis and Catalytic ReactionsComputational Drug Discovery MethodsSynthesis and Biological EvaluationPhenothiazines and Benzothiazines Synthesis and ActivitiesCancer therapeutics and mechanismsClick Chemistry and ApplicationsBioactive Compounds and Antitumor Agents

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025055110165220

Detailed Information

ISSN

1475-6374, 1475-6366

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

5.32

References per Document

69.60

Coverage

1985-1996, 1998-1999, 2002-2026

Scope

Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research. The journal’s focus includes current developments in: Enzymology; Cell biology; Chemical biology; Microbiology; Physiology; Pharmacology leading to drug design; Molecular recognition processes; Distribution and metabolism of biologically active compounds.

Metrics from SCImago Journal Rank 2025. View on SCImago